| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Calcitriol | 31 | 2016 | 130 | 7.700 |
Why?
|
| Vitamin D | 20 | 2016 | 269 | 4.180 |
Why?
|
| Renin-Angiotensin System | 18 | 2015 | 81 | 4.130 |
Why?
|
| Calcitriol | 13 | 2013 | 173 | 2.890 |
Why?
|
| Diabetic Nephropathies | 9 | 2017 | 87 | 2.480 |
Why?
|
| Renin | 11 | 2012 | 67 | 1.880 |
Why?
|
| Signal Transduction | 16 | 2017 | 3393 | 1.860 |
Why?
|
| Gene Expression Regulation | 17 | 2015 | 1977 | 1.660 |
Why?
|
| Podocytes | 6 | 2013 | 33 | 1.470 |
Why?
|
| Intestinal Mucosa | 7 | 2015 | 805 | 1.370 |
Why?
|
| NF-kappa B | 9 | 2017 | 466 | 1.360 |
Why?
|
| Vitamins | 5 | 2010 | 83 | 1.360 |
Why?
|
| Mice | 42 | 2017 | 11792 | 1.230 |
Why?
|
| Epithelial Cells | 8 | 2015 | 689 | 1.140 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 4 | 2010 | 46 | 1.060 |
Why?
|
| Losartan | 7 | 2010 | 30 | 1.010 |
Why?
|
| Animals | 51 | 2017 | 27428 | 1.010 |
Why?
|
| Kidney | 8 | 2017 | 1147 | 1.010 |
Why?
|
| Kidney Diseases | 4 | 2013 | 320 | 0.990 |
Why?
|
| Hyperglycemia | 3 | 2017 | 172 | 0.970 |
Why?
|
| Inflammation | 7 | 2015 | 971 | 0.930 |
Why?
|
| Mesangial Cells | 2 | 2017 | 8 | 0.910 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2017 | 191 | 0.900 |
Why?
|
| Mice, Knockout | 16 | 2015 | 2003 | 0.890 |
Why?
|
| Colitis | 6 | 2015 | 245 | 0.880 |
Why?
|
| MicroRNAs | 5 | 2016 | 556 | 0.850 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 508 | 0.840 |
Why?
|
| Cyclic AMP | 2 | 2017 | 275 | 0.800 |
Why?
|
| Ergocalciferols | 3 | 2010 | 38 | 0.750 |
Why?
|
| Glucose | 2 | 2017 | 630 | 0.730 |
Why?
|
| Vitamin D Deficiency | 5 | 2013 | 104 | 0.720 |
Why?
|
| Promoter Regions, Genetic | 8 | 2017 | 961 | 0.670 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2015 | 581 | 0.660 |
Why?
|
| Energy Metabolism | 2 | 2011 | 279 | 0.610 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2017 | 3 | 0.590 |
Why?
|
| Histones | 2 | 2017 | 331 | 0.570 |
Why?
|
| Macrophages | 4 | 2013 | 574 | 0.570 |
Why?
|
| Albuminuria | 3 | 2016 | 48 | 0.570 |
Why?
|
| Calcium | 8 | 2016 | 1177 | 0.560 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 68 | 0.560 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2013 | 20 | 0.550 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 108 | 0.550 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2015 | 6 | 0.520 |
Why?
|
| Homeostasis | 6 | 2015 | 417 | 0.520 |
Why?
|
| Cardiovascular Diseases | 2 | 2013 | 714 | 0.520 |
Why?
|
| S100 Calcium Binding Protein G | 2 | 2005 | 22 | 0.500 |
Why?
|
| Adipocytes | 3 | 2011 | 163 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 11 | 2015 | 3225 | 0.480 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 383 | 0.480 |
Why?
|
| Interleukin-18 | 2 | 2006 | 26 | 0.480 |
Why?
|
| Interleukin-10 | 1 | 2015 | 151 | 0.470 |
Why?
|
| Receptor, TIE-2 | 1 | 2013 | 18 | 0.460 |
Why?
|
| Pulmonary Fibrosis | 1 | 2015 | 138 | 0.450 |
Why?
|
| Angiopoietin-2 | 1 | 2013 | 17 | 0.450 |
Why?
|
| Keratinocytes | 2 | 2006 | 146 | 0.440 |
Why?
|
| Kidney Glomerulus | 2 | 2013 | 122 | 0.440 |
Why?
|
| Antihypertensive Agents | 4 | 2012 | 251 | 0.440 |
Why?
|
| Blood Pressure | 3 | 2007 | 901 | 0.430 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 64 | 0.430 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 191 | 0.420 |
Why?
|
| Angiotensin II | 5 | 2015 | 93 | 0.420 |
Why?
|
| Angiotensinogen | 2 | 2009 | 5 | 0.420 |
Why?
|
| Atherosclerosis | 2 | 2013 | 257 | 0.410 |
Why?
|
| Mice, Transgenic | 5 | 2015 | 1577 | 0.410 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 92 | 0.410 |
Why?
|
| Receptors, LDL | 1 | 2012 | 55 | 0.400 |
Why?
|
| Vitamin D Response Element | 1 | 2011 | 1 | 0.390 |
Why?
|
| Juxtaglomerular Apparatus | 2 | 2008 | 2 | 0.390 |
Why?
|
| Hypertension | 5 | 2015 | 747 | 0.390 |
Why?
|
| Bone Density Conservation Agents | 1 | 2011 | 46 | 0.370 |
Why?
|
| Inflammation Mediators | 4 | 2013 | 153 | 0.370 |
Why?
|
| Fatty Acids | 1 | 2011 | 134 | 0.370 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2010 | 43 | 0.370 |
Why?
|
| Colon | 4 | 2015 | 511 | 0.360 |
Why?
|
| Membrane Proteins | 3 | 2012 | 1225 | 0.350 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 219 | 0.350 |
Why?
|
| Immunity, Innate | 1 | 2013 | 430 | 0.340 |
Why?
|
| Fibroblasts | 3 | 2010 | 756 | 0.340 |
Why?
|
| Alopecia | 2 | 2016 | 34 | 0.330 |
Why?
|
| Hair Follicle | 2 | 2016 | 29 | 0.330 |
Why?
|
| Protective Agents | 1 | 2009 | 33 | 0.330 |
Why?
|
| Up-Regulation | 5 | 2017 | 728 | 0.320 |
Why?
|
| Polyuria | 1 | 2008 | 7 | 0.320 |
Why?
|
| Thirst | 1 | 2008 | 19 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 1180 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2015 | 699 | 0.310 |
Why?
|
| Humans | 34 | 2016 | 89630 | 0.310 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 127 | 0.300 |
Why?
|
| RNA, Messenger | 8 | 2014 | 2019 | 0.290 |
Why?
|
| Models, Biological | 5 | 2013 | 1767 | 0.290 |
Why?
|
| Ion Channels | 1 | 2009 | 246 | 0.290 |
Why?
|
| Cells, Cultured | 7 | 2016 | 2884 | 0.290 |
Why?
|
| Fibrosis | 3 | 2017 | 234 | 0.290 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 91 | 0.280 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 294 | 0.280 |
Why?
|
| Captopril | 2 | 2004 | 20 | 0.280 |
Why?
|
| Enzyme Inhibitors | 3 | 2009 | 645 | 0.280 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2006 | 12 | 0.270 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 31 | 0.270 |
Why?
|
| I-kappa B Proteins | 1 | 2006 | 54 | 0.270 |
Why?
|
| Interleukin-1 | 1 | 2006 | 72 | 0.260 |
Why?
|
| Calcium, Dietary | 1 | 2005 | 64 | 0.250 |
Why?
|
| Cell Line | 5 | 2013 | 2496 | 0.250 |
Why?
|
| Obesity | 1 | 2011 | 972 | 0.240 |
Why?
|
| Cell Line, Transformed | 2 | 2017 | 155 | 0.240 |
Why?
|
| Acetylation | 2 | 2017 | 132 | 0.240 |
Why?
|
| Disease Progression | 3 | 2015 | 1492 | 0.240 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2017 | 15 | 0.240 |
Why?
|
| Sulfates | 1 | 2004 | 57 | 0.230 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2017 | 78 | 0.230 |
Why?
|
| Gene Expression | 6 | 2009 | 1310 | 0.230 |
Why?
|
| Cardiomegaly | 1 | 2004 | 120 | 0.230 |
Why?
|
| Cation Transport Proteins | 1 | 2004 | 67 | 0.230 |
Why?
|
| Apoptosis | 4 | 2015 | 1720 | 0.220 |
Why?
|
| Symporters | 1 | 2004 | 108 | 0.220 |
Why?
|
| Fibronectins | 2 | 2017 | 101 | 0.220 |
Why?
|
| Time Factors | 5 | 2017 | 5344 | 0.220 |
Why?
|
| RNA Interference | 3 | 2017 | 376 | 0.220 |
Why?
|
| Dextran Sulfate | 3 | 2014 | 68 | 0.210 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2003 | 39 | 0.210 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 541 | 0.210 |
Why?
|
| Mice, Inbred DBA | 2 | 2012 | 149 | 0.190 |
Why?
|
| Fumarates | 2 | 2012 | 19 | 0.180 |
Why?
|
| Amides | 2 | 2012 | 53 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 887 | 0.180 |
Why?
|
| HCT116 Cells | 3 | 2015 | 155 | 0.170 |
Why?
|
| Tight Junctions | 2 | 2013 | 150 | 0.170 |
Why?
|
| Phosphorylation | 3 | 2017 | 1134 | 0.170 |
Why?
|
| Cytokines | 3 | 2015 | 804 | 0.170 |
Why?
|
| DNA, Complementary | 3 | 2004 | 392 | 0.160 |
Why?
|
| Drug Synergism | 2 | 2010 | 306 | 0.160 |
Why?
|
| Oxidation-Reduction | 2 | 2011 | 388 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2010 | 2377 | 0.160 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 2009 | 77 | 0.160 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2009 | 21 | 0.160 |
Why?
|
| Cell Nucleus | 3 | 2015 | 600 | 0.150 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 231 | 0.150 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 785 | 0.150 |
Why?
|
| Acetyl Coenzyme A | 1 | 2017 | 9 | 0.150 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2017 | 16 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 1436 | 0.140 |
Why?
|
| Collagen Type IV | 1 | 2017 | 26 | 0.140 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2015 | 16 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2013 | 698 | 0.140 |
Why?
|
| Citric Acid | 1 | 2017 | 44 | 0.140 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 572 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 89 | 0.140 |
Why?
|
| Thioctic Acid | 1 | 2016 | 1 | 0.140 |
Why?
|
| Finasteride | 1 | 2016 | 8 | 0.140 |
Why?
|
| Salts | 2 | 2008 | 16 | 0.130 |
Why?
|
| Carnitine | 1 | 2016 | 14 | 0.130 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2016 | 12 | 0.130 |
Why?
|
| Sterols | 1 | 2016 | 16 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2016 | 207 | 0.130 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2015 | 41 | 0.130 |
Why?
|
| Parathyroid Hormone | 2 | 2008 | 217 | 0.130 |
Why?
|
| Endocrine System | 2 | 2015 | 17 | 0.130 |
Why?
|
| Transfection | 1 | 2017 | 911 | 0.130 |
Why?
|
| Androgens | 1 | 2016 | 177 | 0.120 |
Why?
|
| Calbindins | 2 | 2005 | 19 | 0.120 |
Why?
|
| Peptide Hormones | 1 | 2015 | 30 | 0.120 |
Why?
|
| DNA Primers | 3 | 2008 | 544 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 80 | 0.120 |
Why?
|
| Phytotherapy | 1 | 2016 | 136 | 0.120 |
Why?
|
| Prostatic Hyperplasia | 1 | 2016 | 91 | 0.120 |
Why?
|
| Base Sequence | 2 | 2010 | 2329 | 0.120 |
Why?
|
| Male | 10 | 2016 | 42561 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2016 | 520 | 0.110 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2013 | 6 | 0.110 |
Why?
|
| Steroid Hydroxylases | 1 | 2013 | 14 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 126 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2013 | 7 | 0.110 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2013 | 23 | 0.110 |
Why?
|
| Water-Electrolyte Balance | 2 | 2003 | 67 | 0.110 |
Why?
|
| Proteinuria | 1 | 2013 | 67 | 0.110 |
Why?
|
| Capillary Permeability | 1 | 2013 | 132 | 0.110 |
Why?
|
| Caco-2 Cells | 2 | 2015 | 123 | 0.110 |
Why?
|
| Bone and Bones | 2 | 2004 | 272 | 0.110 |
Why?
|
| Permeability | 2 | 2015 | 138 | 0.110 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2013 | 69 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 66 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 198 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2013 | 344 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 98 | 0.100 |
Why?
|
| Rats | 3 | 2015 | 4043 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 294 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 730 | 0.100 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 2 | 2009 | 32 | 0.100 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2011 | 1 | 0.100 |
Why?
|
| Phenotype | 2 | 2011 | 2447 | 0.100 |
Why?
|
| Lipolysis | 1 | 2011 | 23 | 0.100 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 25 | 0.100 |
Why?
|
| Retinoid X Receptors | 1 | 2011 | 39 | 0.100 |
Why?
|
| Intestines | 1 | 2015 | 416 | 0.100 |
Why?
|
| Biological Transport, Active | 1 | 2011 | 102 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 167 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 374 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 290 | 0.100 |
Why?
|
| Hypersensitivity | 1 | 2013 | 159 | 0.100 |
Why?
|
| RNA Polymerase II | 1 | 2011 | 57 | 0.090 |
Why?
|
| Thermogenesis | 1 | 2011 | 42 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 262 | 0.090 |
Why?
|
| Kidney Tubules | 1 | 2011 | 92 | 0.090 |
Why?
|
| Aorta | 1 | 2012 | 288 | 0.090 |
Why?
|
| Organ Specificity | 1 | 2011 | 273 | 0.090 |
Why?
|
| Lipids | 1 | 2012 | 273 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2013 | 461 | 0.090 |
Why?
|
| Angiotensin I | 1 | 2010 | 7 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 387 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 195 | 0.090 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 34 | 0.090 |
Why?
|
| Receptors, Leptin | 1 | 2010 | 32 | 0.090 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 47 | 0.090 |
Why?
|
| Cholesterol | 1 | 2012 | 360 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2013 | 336 | 0.090 |
Why?
|
| Locomotion | 1 | 2011 | 140 | 0.090 |
Why?
|
| Collagen Type I | 1 | 2010 | 72 | 0.090 |
Why?
|
| Risk | 1 | 2011 | 657 | 0.090 |
Why?
|
| Glomerular Basement Membrane | 1 | 2009 | 4 | 0.080 |
Why?
|
| Female | 8 | 2016 | 46361 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 127 | 0.080 |
Why?
|
| Uncoupling Protein 3 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Uncoupling Protein 2 | 1 | 2009 | 11 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2011 | 641 | 0.080 |
Why?
|
| RNA | 2 | 2004 | 581 | 0.080 |
Why?
|
| Uncoupling Protein 1 | 1 | 2009 | 38 | 0.080 |
Why?
|
| Creatinine | 1 | 2010 | 294 | 0.080 |
Why?
|
| Prevalence | 1 | 2013 | 1246 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 557 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2008 | 1527 | 0.080 |
Why?
|
| Streptozocin | 1 | 2008 | 55 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 983 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2008 | 68 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2009 | 245 | 0.080 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Drug Combinations | 1 | 2008 | 203 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 558 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 1160 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 245 | 0.080 |
Why?
|
| Sodium | 1 | 2009 | 331 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 324 | 0.070 |
Why?
|
| Ulcer | 1 | 2007 | 37 | 0.070 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2007 | 19 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 201 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 740 | 0.070 |
Why?
|
| Cholecalciferol | 1 | 2007 | 35 | 0.070 |
Why?
|
| Response Elements | 1 | 2007 | 65 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2007 | 110 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1847 | 0.070 |
Why?
|
| Drug Design | 1 | 2007 | 127 | 0.070 |
Why?
|
| Lung | 1 | 2013 | 1266 | 0.070 |
Why?
|
| Molecular Structure | 1 | 2007 | 290 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 415 | 0.070 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2006 | 31 | 0.070 |
Why?
|
| Phorbol Esters | 1 | 2006 | 22 | 0.070 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2006 | 12 | 0.070 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2006 | 42 | 0.070 |
Why?
|
| Ligands | 1 | 2007 | 445 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 289 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 565 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 1226 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2012 | 762 | 0.060 |
Why?
|
| RNA Stability | 1 | 2006 | 89 | 0.060 |
Why?
|
| Antibodies | 1 | 2007 | 354 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 740 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2006 | 261 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2012 | 740 | 0.060 |
Why?
|
| Wound Healing | 1 | 2007 | 360 | 0.060 |
Why?
|
| Pregnancy | 1 | 2012 | 3027 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1944 | 0.060 |
Why?
|
| Rickets | 1 | 2004 | 5 | 0.060 |
Why?
|
| Calbindin 1 | 1 | 2004 | 11 | 0.060 |
Why?
|
| Duodenum | 1 | 2005 | 103 | 0.060 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2004 | 39 | 0.060 |
Why?
|
| Parathyroid Glands | 1 | 2004 | 74 | 0.060 |
Why?
|
| Chromatin | 1 | 2007 | 400 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2004 | 258 | 0.060 |
Why?
|
| Glutathione | 1 | 2004 | 108 | 0.060 |
Why?
|
| Peptides | 1 | 2007 | 649 | 0.060 |
Why?
|
| Cell Movement | 1 | 2007 | 785 | 0.060 |
Why?
|
| Weight Gain | 1 | 2004 | 119 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2004 | 123 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 122 | 0.060 |
Why?
|
| Eating | 1 | 2004 | 166 | 0.060 |
Why?
|
| Biomarkers | 1 | 2010 | 1770 | 0.050 |
Why?
|
| Submandibular Gland | 1 | 2003 | 17 | 0.050 |
Why?
|
| Aldosterone | 1 | 2003 | 56 | 0.050 |
Why?
|
| Sodium, Dietary | 1 | 2002 | 8 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2004 | 245 | 0.050 |
Why?
|
| Drinking Behavior | 1 | 2002 | 13 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 138 | 0.050 |
Why?
|
| Keratin-14 | 1 | 2002 | 5 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 646 | 0.050 |
Why?
|
| Keratins | 1 | 2002 | 63 | 0.050 |
Why?
|
| Hypocalcemia | 1 | 2002 | 44 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 426 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2006 | 438 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2007 | 948 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2002 | 114 | 0.050 |
Why?
|
| Transgenes | 1 | 2002 | 185 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2002 | 268 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 314 | 0.050 |
Why?
|
| DNA | 1 | 2007 | 1309 | 0.050 |
Why?
|
| Water | 1 | 2003 | 284 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 695 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 306 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 996 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 639 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2014 | 795 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 1201 | 0.040 |
Why?
|
| Mutation | 1 | 2011 | 4162 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2002 | 443 | 0.040 |
Why?
|
| Liver | 1 | 2004 | 1210 | 0.040 |
Why?
|
| Skin | 1 | 2002 | 585 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2011 | 8274 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1801 | 0.040 |
Why?
|
| Chemoprevention | 1 | 2016 | 92 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2015 | 94 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 162 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2014 | 50 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 47 | 0.030 |
Why?
|
| Adenoma | 1 | 2016 | 247 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 267 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 1057 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 421 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 282 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 340 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2015 | 510 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 691 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1863 | 0.020 |
Why?
|
| Microvilli | 1 | 2009 | 43 | 0.020 |
Why?
|
| Ion Transport | 1 | 2009 | 81 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1654 | 0.020 |
Why?
|
| Exocytosis | 1 | 2009 | 109 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 275 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2009 | 116 | 0.020 |
Why?
|
| Azo Compounds | 1 | 2008 | 13 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 34 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 128 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 95 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2007 | 23 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 82 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 99 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 123 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2007 | 126 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 199 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 127 | 0.020 |
Why?
|
| Cell Division | 1 | 2007 | 696 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 19237 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 345 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 26069 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1601 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2565 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 1555 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 26699 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 6834 | 0.010 |
Why?
|